Pathway-selective 5-HT1AR agonist as a rapid antidepressant strategy
Abstract
No abstract availableKeywords
Funding Information
- Tianjin Municipal Science and Technology Committee (23JCQNJC00940)
- National Key Research and Development Program of China (2025YFA1309100)
- University of Science and Technology of China (KY9100000088)
- National Natural Science Foundation of China (GG9100007022)
- National Natural Science Foundation of China (32430046)
- National Natural Science Foundation of China (32400848)
- National Natural Science Foundation of China (82525102)
- National Natural Science Foundation of China (82204223)
- Chinese Academy of Sciences (YSBR-013)
This publication has 68 references indexed in Scilit:
- Gepirone Extended-Release: First ApprovalDrugs, 2023
- Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin ReceptorCell, 2020
- UCSF ChimeraX: Structure visualization for researchers, educators, and developersProtein Science, 2020
- The 5-HT1A receptor: Signaling to behaviorBiochimie, 2019
- Serotonin 5-HT1A Receptors as Targets for Agents to Treat Psychiatric Disorders: Rationale and Current Status of ResearchCNS Drugs, 2013
- Mice deficient in the alpha subunit of Gz show changes in pre-pulse inhibition, anxiety and responses to 5-HT1A receptor stimulation, which are strongly dependent on the genetic backgroundPsychopharmacology, 2007
- Stereoselectivity of 8-OH-DPAT toward the serotonin 5-HT1A receptor: Biochemical and molecular modeling studyBiochemical Pharmacology, 2006
- Effect of Pindolol on the Function of Pre- and Postsynaptic 5-HT1A Receptors: In Vivo Microdialysis and Electrophysiological Studies in the Rat BrainNeuropsychopharmacology, 1996
- Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (−)-pindolol, an antagonist at 5-HT1A receptorsNeurochemical Research, 1996
- Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake InhibitorsArchives of General Psychiatry, 1994